150 related articles for article (PubMed ID: 817022)
1. Mode of action and quantitative structure-activity correlations of tuberculostatic drugs of the isonicotinic acid hydrazide type.
Seydel JK; Schaper KJ; Wempe E; Cordes HP
J Med Chem; 1976 Apr; 19(4):483-92. PubMed ID: 817022
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of graphical invariants in quantitative structure-activity correlations of tuberculostatic drugs of the isonicotinic acid hydrazide type.
Bagchi MC; Maiti BC; Mills D; Basak SC
J Mol Model; 2004 Apr; 10(2):102-11. PubMed ID: 14691675
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and mechanistic investigation of iron(II) complexes of isoniazid and derivatives as a redox-mediated activation strategy for anti-tuberculosis therapy.
Laborde J; Deraeve C; de Mesquita Vieira FG; Sournia-Saquet A; Rechignat L; Villela AD; Abbadi BL; Macchi FS; Pissinate K; Bizarro CV; Machado P; Basso LA; Pratviel G; de França Lopes LG; Sousa EHS; Bernardes-Génisson V
J Inorg Biochem; 2018 Feb; 179():71-81. PubMed ID: 29175704
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antimycobacterial activity of isoniazid derivatives from renewable fatty acids.
Rodrigues MO; Cantos JB; D'Oca CR; Soares KL; Coelho TS; Piovesan LA; Russowsky D; da Silva PA; D'Oca MG
Bioorg Med Chem; 2013 Nov; 21(22):6910-4. PubMed ID: 24103427
[TBL] [Abstract][Full Text] [Related]
5. Novel isoniazid derivative as promising antituberculosis agent.
Volynets GP; Tukalo MA; Bdzhola VG; Derkach NM; Gumeniuk MI; Tarnavskiy SS; Yarmoluk SM
Future Microbiol; 2020 Jul; 15(10):869-879. PubMed ID: 32662670
[No Abstract] [Full Text] [Related]
6. Designing new antitubercular isoniazid derivatives with improved reactivity and membrane trafficking abilities.
de Faria CF; Moreira T; Lopes P; Costa H; Krewall JR; Barton CM; Santos S; Goodwin D; Machado D; Viveiros M; Machuqueiro M; Martins F
Biomed Pharmacother; 2021 Dec; 144():112362. PubMed ID: 34710838
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic investigation of the oxidation of hydrazides: implications for the activation of the TB drug isoniazid.
Amos RI; Gourlay BS; Yates BF; Schiesser CH; Lewis TW; Smith JA
Org Biomol Chem; 2013 Jan; 11(1):170-6. PubMed ID: 23165368
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of novel isoniazid derivatives with potent antitubercular activity.
Martins F; Santos S; Ventura C; Elvas-Leitão R; Santos L; Vitorino S; Reis M; Miranda V; Correia HF; Aires-de-Sousa J; Kovalishyn V; Latino DA; Ramos J; Viveiros M
Eur J Med Chem; 2014 Jun; 81():119-38. PubMed ID: 24836065
[TBL] [Abstract][Full Text] [Related]
9. Fullerene isoniazid conjugate--a tuberculostat with increased lipophilicity: synthesis and evaluation of antimycobacterial activity.
Kumar A; Patel G; Menon SK
Chem Biol Drug Des; 2009 May; 73(5):553-7. PubMed ID: 19366360
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and bioevaluation of some new isoniazid derivatives.
Matei L; Bleotu C; Baciu I; Draghici C; Ionita P; Paun A; Chifiriuc MC; Sbarcea A; Zarafu I
Bioorg Med Chem; 2013 Sep; 21(17):5355-61. PubMed ID: 23823011
[TBL] [Abstract][Full Text] [Related]
11. New lipophilic isoniazid derivatives and their 1,3,4-oxadiazole analogues: Synthesis, antimycobacterial activity and investigation of their mechanism of action.
Vosátka R; Krátký M; Švarcová M; Janoušek J; Stolaříková J; Madacki J; Huszár S; Mikušová K; Korduláková J; Trejtnar F; Vinšová J
Eur J Med Chem; 2018 May; 151():824-835. PubMed ID: 29679902
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of isonicotinic acid N'-arylidene-N-[2-oxo-2-(4-aryl-piperazin-1-yl)-ethyl]-hydrazides as antituberculosis agents.
Sinha N; Jain S; Tilekar A; Upadhayaya RS; Kishore N; Jana GH; Arora SK
Bioorg Med Chem Lett; 2005 Mar; 15(6):1573-6. PubMed ID: 15745799
[TBL] [Abstract][Full Text] [Related]
13. Isonicotinoylhydrazone analogs of isoniazid: relationship between superoxide scavenging and tuberculostatic activities.
Georgieva N; Gadjeva V
Biochemistry (Mosc); 2002 May; 67(5):588-91. PubMed ID: 12059780
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity correlations in a homologous series of 2-substituted isonicotinic acid hydrazides.
Schaper KJ; Seydel JK
Experientia Suppl; 1976; 23():119-24. PubMed ID: 821772
[No Abstract] [Full Text] [Related]
15. Synthesis and antituberculosis activity of indole-pyridine derived hydrazides, hydrazide-hydrazones, and thiosemicarbazones.
Velezheva V; Brennan P; Ivanov P; Kornienko A; Lyubimov S; Kazarian K; Nikonenko B; Majorov K; Apt A
Bioorg Med Chem Lett; 2016 Feb; 26(3):978-985. PubMed ID: 26725953
[TBL] [Abstract][Full Text] [Related]
16. [Synthesis and antituberculosis activity of the derivatives of glycoside steviolbioside from the plant Stevia rebaudiana and diterpenoid isosteviol containing hydrazone, hydrazide and pyridinoyl moieties].
Kataev VE; Strobykina IIu; Andreeva OV; Garifullin BF; Sharipova RR; Mironov VF; Chestnova RV
Bioorg Khim; 2011; 37(4):542-51. PubMed ID: 22096997
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological activities of some new isonicotinic acid 2-(2-hydroxy-8-substituted-tricyclo[7.3.1.0(2.7)]tridec-13-ylidene)-hydrazides.
Matei L; Bleotu C; Baciu I; Diaconu CC; Hanganu A; Banu O; Ionita P; Paun A; Tatibouët A; Zarafu I
Bioorg Med Chem; 2015 Feb; 23(3):401-10. PubMed ID: 25557899
[TBL] [Abstract][Full Text] [Related]
18. [Antituberculotics. 20. Pyridine quaternization as a model reaction for structure activity relationships of 6-halogen-2-alkyl-isonicotinic acid hydrazides].
Waisser K; Rubácek F; Karlícek R; Sova J; Celadník M; Palát K
Pharmazie; 1979; 34(3):197. PubMed ID: 450961
[No Abstract] [Full Text] [Related]
19. Synthesis and antimycobacterial activity of a novel series of isonicotinylhydrazide derivatives.
Jaju S; Palkar M; Maddi VS; Ronad P; Mamledesai S; Satyanarayana D; Ghatole M
Arch Pharm (Weinheim); 2009 Dec; 342(12):723-31. PubMed ID: 19899098
[TBL] [Abstract][Full Text] [Related]
20. [Study of the antitubercular activity of new derivatives of aromatic hydrazides. IX. Antitubercular activity in vitro of several new substituted isonicotinoylhydrazides, diphenylsulfonylhydrazides and diphenylsulfonylhydrazidones].
Teitel A; Stroescu V; Demetrescu C; Beneş H; Chiriţă C; Gane P; Steflea D; Chiculescu O
Fiziol Norm Patol; 1967; 13(6):551-60. PubMed ID: 4969837
[No Abstract] [Full Text] [Related]
[Next] [New Search]
